# Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)

> **NCT00379470** · PHASE3 · COMPLETED · sponsor: **NovoCure Ltd.** · enrollment: 236 (actual)

## Conditions studied

- Recurrent Glioblastoma Multiforme

## Interventions

- **DEVICE:** NovoTTF-100A

## Key facts

- **NCT ID:** NCT00379470
- **Lead sponsor:** NovoCure Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-11
- **Final completion:** 2011-01
- **Target enrollment:** 236 (ACTUAL)
- **Last updated:** 2012-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00379470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00379470, "Effect of NovoTTF-100A in Recurrent Glioblastoma Multiforme (GBM)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00379470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*